News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
102last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Medical Device Network5d agoneutral
Spinal cord stimulator lawsuits surge: what is going wrong?Investor's Business Daily9d agoneutral
Dexcom Shakes Off Abbott-Tied Malaise As U.S. Wearables Market Takes OffAssociated Press55d agoneutral
Abbott agrees to settlement over closure of largest baby formula plant in the USThe Wall Street Journal55d agoneutral
Abbott Agrees to $385 Million Settlement in Baby Formula CaseThe Daily Upside69d agoneutral
Abbott Introduces America’s First Liquid Baby Formula With Whole Milk24/7 Wall St.69d agoneutral
Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising DividendsInvestor's Business Daily69d agoneutral
How Abbott Labs Is Embracing RFK Jr.'s Make America Healthy Again MovementBenzinga73d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose TrackingBenzinga74d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose TrackingThe Wall Street Journal80d agoneutral
Abbott to Pay $670 Million to Settle Baby-Formula LitigationSimply Wall St.83d agoneutral
Abbott (ABT) Stock Looks Reasonable On Earnings With Stronger Cash FlowInvesting.com87d agoneutral
Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffleInsider Monkey96d agoneutral
Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?Insider Monkey104d agoneutral
Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed GrowthSimply Wall St.109d agoneutral
Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value?The Wall Street Journal113d agoneutral
The Justice Department Is Pulling Back on Prosecuting Corporate Crime